| ■ 영문 제목 : Global Clostridium Diagnostics Market 2023-2027 
 
  | 
  | ■ 상품코드 : IRTNTR75006-23 
■ 조사/발행회사 : Technavio 
■ 발행일 : 2023년 2월 ■ 페이지수 : 약120 
■ 작성언어 : 영문 
■ 보고서 형태 : PDF 
■ 납품 방식 : E메일 (24시간 이내) 
■ 조사대상 지역 : 북미, 유럽, 아시아 태평양, 기타 지역 
■ 산업 분야 : 의료 
 | 
■ 판매가격 / 옵션 
(부가세 10% 별도)	
| Single User (1명 열람용) | USD2,500 ⇒환산₩3,500,000 | 견적의뢰/주문/질문 | 
| Enterprise License (동일기업내 공유가능) | USD4,000 ⇒환산₩5,600,000 | 견적의뢰/주문/질문 | 
※가격옵션 설명 
- 납기는 즉일~2일소요됩니다. 3일이상 소요되는 경우는 별도표기 또는 연락드립니다. 
- 지불방법은 계좌이체/무통장입금 또는 카드결제입니다.
  | 
Technavio사는 세계의 클로스트리듐 진단 시장 규모가 2022년부터 2027년 사이에 2,148.4백만 달러에 이르며며, 예측 기간 동안 연평균 13.69% 성장할 것으로 전망하고 있습니다. 본 조사 보고서는 세계의 클로스트리듐 진단 시장에 대해 조사 및 분석하여, 개요, 시장 현황, 시장 규모 예측, 과거 시장 규모, Five Force 분석, 기술별 (면역 검사, 분자 진단) 분석, 제품별 (클로스트리듐 디피실, 웰치균, 보툴리누스균, 파상풍균, 기타) 분석, 최종 용도별 (병원, 독립 연구소, 진료소) 분석, 고객 현황, 지역별 현황 (북미, 유럽, 아시아 태평양, 기타 지역, 미국, 독일, 영국, 중국, 캐나다) 분석, 성장 요인/과제/동향, 기업 현황, 기업 분석 등의 내용을 게재하고 있습니다. 또한 본 자료는 AstraZeneca Plc, Beckman Coulter Inc., Becton Dickinson and Co., bioMerieux SA, DiaSorin SpA, F. Hoffmann La Roche Ltd., Ferring BV, Fujirebio Holdings Inc., Hologic Inc., Huvepharma, Meridian Bioscience Inc. 와 같은 기업 정보를 포함하고 있습니다. 
 
・개요 
・시장 현황 
・시장 규모 예측 
・과거 시장 규모 
・Five Force 분석 
 
・세계의 클로스트리듐 진단 시장 규모 : 기술별 
 - 면역 검사 기술의 시장 규모 
 - 분자 진단 기술의 시장 규모 
 
・세계의 클로스트리듐 진단 시장 규모 : 제품별 
 - 클로스트리듐 디피실의 시장 규모 
 - 웰치균의 시장 규모 
 - 보툴리누스균의 시장 규모 
 - 파상풍균의 시장 규모 
 - 기타 제품의 시장 규모 
 
・세계의 클로스트리듐 진단 시장 규모 : 최종 용도별 
 - 병원에서 사용하는 클로스트리듐 진단의 시장 규모 
 - 독립 연구소에서 사용하는 클로스트리듐 진단의 시장 규모 
 - 진료소에서 사용하는 클로스트리듐 진단의 시장 규모 
 
・지역별 현황 
 - 북미의 클로스트리듐 진단 시장 규모 
 - 유럽의 클로스트리듐 진단 시장 규모 
 - 아시아 태평양의 클로스트리듐 진단 시장 규모 
 - 기타 지역의 클로스트리듐 진단 시장 규모 
 - 미국의 클로스트리듐 진단 시장 규모 
 - 독일의 클로스트리듐 진단 시장 규모 
 - 영국의 클로스트리듐 진단 시장 규모 
 - 중국의 클로스트리듐 진단 시장 규모 
 - 캐나다의 클로스트리듐 진단 시장 규모 
 
・성장 요인/과제/동향 
・기업 현황 
・기업 분석 
 
Technavio 사는 이익, 가격, 경쟁, 프로모션과 같은 주요 매개 변수를 분석하여, 다수의 소스로부터 데이터를 조사, 통합 및 합산하여 클로스트리듐 진단 시장에 대한 상세하고 종합적인 결과를 제공합니다. 또한, 주요 산업의 영향 요인을 분석하여 시장의 다양한 관점을 제시합니다. 제시된 데이터는 포괄적이고 신뢰할 수 있으며, 1차 및 2차에 걸친 광범위한 조사 결과입니다. 덧붙여 Technavio 사의 시장 조사 보고서는 정확한 클로스트리듐 진단 시장 성장을 예측하기 위해, 정성적 및 정량적 조사를 사용하여, 명확한 경쟁 현황과 상세한 벤더 선택 방법 및 분석을 제공합니다. | 
■ 보고서 개요Global Clostridium Diagnostics Market 2023-2027Technavio has been monitoring the clostridium diagnostics market and is forecast to grow by $2148.4 mn during 2022-2027, accelerating at a CAGR of 13.69% during the forecast period. Our report on the clostridium diagnostics market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.
The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by growing prevalence of CDI, rise in aging population, and development of novel therapies.
Technavio’s clostridium diagnostics market is segmented as below:
By Technology
•     Immunoassays
•     Molecular diagnostics
By Product
•     Clostridium difficile
•     Clostridium perfringens
•     Clostridium botulinum
•     Clostridium tetani
•     Clostridium sordellii
By End-user
•     Hospitals
•     Independent laboratories
•     Physicians clinics
By Geography
•     North America
•     Europe
•     Asia
•     Rest of World (ROW)
This study identifies the development of new vaccines as one of the prime reasons driving the clostridium diagnostics market growth during the next few years. Also, growing use of immunoinformatics for vaccine research and high investment in research and development will lead to sizable demand in the market.
Technavio presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters. Our report on the clostridium diagnostics market covers the following areas:
•     Clostridium diagnostics market sizing
•     Clostridium diagnostics market forecast
•     Clostridium diagnostics market industry analysis
Technavio’s robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading clostridium diagnostics market vendors that include AstraZeneca Plc, Beckman Coulter Inc., Becton Dickinson and Co., bioMerieux SA, DiaSorin SpA, F. Hoffmann La Roche Ltd., Ferring BV, Fujirebio Holdings Inc., Hologic Inc., Huvepharma, Meridian Bioscience Inc., Novartis AG, Olympus Corp., Pfizer Inc., QIAGEN NV, Siemens AG, Summit Therapeutics Inc., TECHLAB Inc., Thermo Fisher Scientific Inc., and Trinity Biotech Plc. Also, the clostridium diagnostics market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.
Technavio presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research – both primary and secondary. Technavio’s market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast accurate market growth.
■ 보고서 목차•     1 Executive Summary 
o     1.1 Market overview 
o     Exhibit 01: Executive Summary – Chart on Market Overview 
o     Exhibit 02: Executive Summary – Data Table on Market Overview 
o     Exhibit 03: Executive Summary – Chart on Global Market Characteristics 
o     Exhibit 04: Executive Summary – Chart on Market By Geographical Landscape 
o     Exhibit 05: Executive Summary – Chart on Market Segmentation by Technology 
o     Exhibit 06: Executive Summary – Chart on Market Segmentation by Product 
o     Exhibit 07: Executive Summary – Chart on Market Segmentation by End-user 
o     Exhibit 08: Executive Summary – Chart on Incremental Growth 
o     Exhibit 09: Executive Summary – Data Table on Incremental Growth 
o     Exhibit 10: Executive Summary – Chart on Vendor Market Positioning 
•     2 Market Landscape 
o     2.1 Market ecosystem 
o     Exhibit 11: Parent market 
o     Exhibit 12: Market Characteristics 
•     3 Market Sizing 
o     3.1 Market definition 
o     Exhibit 13: Offerings of vendors included in the market definition 
o     3.2 Market segment analysis 
o     Exhibit 14: Market segments 
o     3.3 Market size 2022 
o     3.4 Market outlook: Forecast for 2022-2027 
o     Exhibit 15: Chart on Global – Market size and forecast 2022-2027 ($ million) 
o     Exhibit 16: Data Table on Global – Market size and forecast 2022-2027 ($ million) 
o     Exhibit 17: Chart on Global Market: Year-over-year growth 2022-2027 (%) 
o     Exhibit 18: Data Table on Global Market: Year-over-year growth 2022-2027 (%) 
•     4 Historic Market Size 
o     4.1 Global clostridium diagnostics market 2017 – 2021 
o     Exhibit 19: Historic Market Size – Data Table on Global clostridium diagnostics market 2017 – 2021 ($ million) 
o     4.2 Technology Segment Analysis 2017 – 2021 
o     Exhibit 20: Historic Market Size – Technology Segment 2017 – 2021 ($ million) 
o     4.3 Product Segment Analysis 2017 – 2021 
o     Exhibit 21: Historic Market Size – Product Segment 2017 – 2021 ($ million) 
o     4.4 End user Segment Analysis 2017 – 2021 
o     Exhibit 22: Historic Market Size – End user Segment 2017 – 2021 ($ million) 
o     4.5 Geography Segment Analysis 2017 – 2021 
o     Exhibit 23: Historic Market Size – Geography Segment 2017 – 2021 ($ million) 
o     4.6 Country Segment Analysis 2017 – 2021 
o     Exhibit 24: Historic Market Size – Country Segment 2017 – 2021 ($ million) 
•     5 Five Forces Analysis 
o     5.1 Five forces summary 
o     Exhibit 25: Five forces analysis – Comparison between 2022 and 2027 
o     5.2 Bargaining power of buyers 
o     Exhibit 26: Chart on Bargaining power of buyers – Impact of key factors 2022 and 2027 
o     5.3 Bargaining power of suppliers 
o     Exhibit 27: Bargaining power of suppliers – Impact of key factors in 2022 and 2027 
o     5.4 Threat of new entrants 
o     Exhibit 28: Threat of new entrants – Impact of key factors in 2022 and 2027 
o     5.5 Threat of substitutes 
o     Exhibit 29: Threat of substitutes – Impact of key factors in 2022 and 2027 
o     5.6 Threat of rivalry 
o     Exhibit 30: Threat of rivalry – Impact of key factors in 2022 and 2027 
o     5.7 Market condition 
o     Exhibit 31: Chart on Market condition – Five forces 2022 and 2027 
•     6 Market Segmentation by Technology 
o     6.1 Market segments 
o     Exhibit 32: Chart on Technology – Market share 2022-2027 (%) 
o     Exhibit 33: Data Table on Technology – Market share 2022-2027 (%) 
o     6.2 Comparison by Technology 
o     Exhibit 34: Chart on Comparison by Technology 
o     Exhibit 35: Data Table on Comparison by Technology 
o     6.3 Immunoassays – Market size and forecast 2022-2027 
o     Exhibit 36: Chart on Immunoassays – Market size and forecast 2022-2027 ($ million) 
o     Exhibit 37: Data Table on Immunoassays – Market size and forecast 2022-2027 ($ million) 
o     Exhibit 38: Chart on Immunoassays – Year-over-year growth 2022-2027 (%) 
o     Exhibit 39: Data Table on Immunoassays – Year-over-year growth 2022-2027 (%) 
o     6.4 Molecular diagnostics – Market size and forecast 2022-2027 
o     Exhibit 40: Chart on Molecular diagnostics – Market size and forecast 2022-2027 ($ million) 
o     Exhibit 41: Data Table on Molecular diagnostics – Market size and forecast 2022-2027 ($ million) 
o     Exhibit 42: Chart on Molecular diagnostics – Year-over-year growth 2022-2027 (%) 
o     Exhibit 43: Data Table on Molecular diagnostics – Year-over-year growth 2022-2027 (%) 
o     6.5 Market opportunity by Technology 
o     Exhibit 44: Market opportunity by Technology ($ million) 
o     Exhibit 45: Data Table on Market opportunity by Technology ($ million) 
•     7 Market Segmentation by Product 
o     7.1 Market segments 
o     Exhibit 46: Chart on Product – Market share 2022-2027 (%) 
o     Exhibit 47: Data Table on Product – Market share 2022-2027 (%) 
o     7.2 Comparison by Product 
o     Exhibit 48: Chart on Comparison by Product 
o     Exhibit 49: Data Table on Comparison by Product 
o     7.3 Clostridium difficile – Market size and forecast 2022-2027 
o     Exhibit 50: Chart on Clostridium difficile – Market size and forecast 2022-2027 ($ million) 
o     Exhibit 51: Data Table on Clostridium difficile – Market size and forecast 2022-2027 ($ million) 
o     Exhibit 52: Chart on Clostridium difficile – Year-over-year growth 2022-2027 (%) 
o     Exhibit 53: Data Table on Clostridium difficile – Year-over-year growth 2022-2027 (%) 
o     7.4 Clostridium perfringens – Market size and forecast 2022-2027 
o     Exhibit 54: Chart on Clostridium perfringens – Market size and forecast 2022-2027 ($ million) 
o     Exhibit 55: Data Table on Clostridium perfringens – Market size and forecast 2022-2027 ($ million) 
o     Exhibit 56: Chart on Clostridium perfringens – Year-over-year growth 2022-2027 (%) 
o     Exhibit 57: Data Table on Clostridium perfringens – Year-over-year growth 2022-2027 (%) 
o     7.5 Clostridium botulinum – Market size and forecast 2022-2027 
o     Exhibit 58: Chart on Clostridium botulinum – Market size and forecast 2022-2027 ($ million) 
o     Exhibit 59: Data Table on Clostridium botulinum – Market size and forecast 2022-2027 ($ million) 
o     Exhibit 60: Chart on Clostridium botulinum – Year-over-year growth 2022-2027 (%) 
o     Exhibit 61: Data Table on Clostridium botulinum – Year-over-year growth 2022-2027 (%) 
o     7.6 Clostridium tetani – Market size and forecast 2022-2027 
o     Exhibit 62: Chart on Clostridium tetani – Market size and forecast 2022-2027 ($ million) 
o     Exhibit 63: Data Table on Clostridium tetani – Market size and forecast 2022-2027 ($ million) 
o     Exhibit 64: Chart on Clostridium tetani – Year-over-year growth 2022-2027 (%) 
o     Exhibit 65: Data Table on Clostridium tetani – Year-over-year growth 2022-2027 (%) 
o     7.7 Clostridium sordellii – Market size and forecast 2022-2027 
o     Exhibit 66: Chart on Clostridium sordellii – Market size and forecast 2022-2027 ($ million) 
o     Exhibit 67: Data Table on Clostridium sordellii – Market size and forecast 2022-2027 ($ million) 
o     Exhibit 68: Chart on Clostridium sordellii – Year-over-year growth 2022-2027 (%) 
o     Exhibit 69: Data Table on Clostridium sordellii – Year-over-year growth 2022-2027 (%) 
o     7.8 Market opportunity by Product 
o     Exhibit 70: Market opportunity by Product ($ million) 
o     Exhibit 71: Data Table on Market opportunity by Product ($ million) 
•     8 Market Segmentation by End-user 
o     8.1 Market segments 
o     Exhibit 72: Chart on End-user – Market share 2022-2027 (%) 
o     Exhibit 73: Data Table on End-user – Market share 2022-2027 (%) 
o     8.2 Comparison by End-user 
o     Exhibit 74: Chart on Comparison by End-user 
o     Exhibit 75: Data Table on Comparison by End-user 
o     8.3 Hospitals – Market size and forecast 2022-2027 
o     Exhibit 76: Chart on Hospitals – Market size and forecast 2022-2027 ($ million) 
o     Exhibit 77: Data Table on Hospitals – Market size and forecast 2022-2027 ($ million) 
o     Exhibit 78: Chart on Hospitals – Year-over-year growth 2022-2027 (%) 
o     Exhibit 79: Data Table on Hospitals – Year-over-year growth 2022-2027 (%) 
o     8.4 Independent laboratories – Market size and forecast 2022-2027 
o     Exhibit 80: Chart on Independent laboratories – Market size and forecast 2022-2027 ($ million) 
o     Exhibit 81: Data Table on Independent laboratories – Market size and forecast 2022-2027 ($ million) 
o     Exhibit 82: Chart on Independent laboratories – Year-over-year growth 2022-2027 (%) 
o     Exhibit 83: Data Table on Independent laboratories – Year-over-year growth 2022-2027 (%) 
o     8.5 Physicians clinics – Market size and forecast 2022-2027 
o     Exhibit 84: Chart on Physicians clinics – Market size and forecast 2022-2027 ($ million) 
o     Exhibit 85: Data Table on Physicians clinics – Market size and forecast 2022-2027 ($ million) 
o     Exhibit 86: Chart on Physicians clinics – Year-over-year growth 2022-2027 (%) 
o     Exhibit 87: Data Table on Physicians clinics – Year-over-year growth 2022-2027 (%) 
o     8.6 Market opportunity by End-user 
o     Exhibit 88: Market opportunity by End-user ($ million) 
o     Exhibit 89: Data Table on Market opportunity by End-user ($ million) 
•     9 Customer Landscape 
o     9.1 Customer landscape overview 
o     Exhibit 90: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria 
•     10 Geographic Landscape 
o     10.1 Geographic segmentation 
o     Exhibit 91: Chart on Market share By Geographical Landscape 2022-2027 (%) 
o     Exhibit 92: Data Table on Market share By Geographical Landscape 2022-2027 (%) 
o     10.2 Geographic comparison 
o     Exhibit 93: Chart on Geographic comparison 
o     Exhibit 94: Data Table on Geographic comparison 
o     10.3 North America – Market size and forecast 2022-2027 
o     Exhibit 95: Chart on North America – Market size and forecast 2022-2027 ($ million) 
o     Exhibit 96: Data Table on North America – Market size and forecast 2022-2027 ($ million) 
o     Exhibit 97: Chart on North America – Year-over-year growth 2022-2027 (%) 
o     Exhibit 98: Data Table on North America – Year-over-year growth 2022-2027 (%) 
o     10.4 Europe – Market size and forecast 2022-2027 
o     Exhibit 99: Chart on Europe – Market size and forecast 2022-2027 ($ million) 
o     Exhibit 100: Data Table on Europe – Market size and forecast 2022-2027 ($ million) 
o     Exhibit 101: Chart on Europe – Year-over-year growth 2022-2027 (%) 
o     Exhibit 102: Data Table on Europe – Year-over-year growth 2022-2027 (%) 
o     10.5 Asia – Market size and forecast 2022-2027 
o     Exhibit 103: Chart on Asia – Market size and forecast 2022-2027 ($ million) 
o     Exhibit 104: Data Table on Asia – Market size and forecast 2022-2027 ($ million) 
o     Exhibit 105: Chart on Asia – Year-over-year growth 2022-2027 (%) 
o     Exhibit 106: Data Table on Asia – Year-over-year growth 2022-2027 (%) 
o     10.6 Rest of World (ROW) – Market size and forecast 2022-2027 
o     Exhibit 107: Chart on Rest of World (ROW) – Market size and forecast 2022-2027 ($ million) 
o     Exhibit 108: Data Table on Rest of World (ROW) – Market size and forecast 2022-2027 ($ million) 
o     Exhibit 109: Chart on Rest of World (ROW) – Year-over-year growth 2022-2027 (%) 
o     Exhibit 110: Data Table on Rest of World (ROW) – Year-over-year growth 2022-2027 (%) 
o     10.7 US – Market size and forecast 2022-2027 
o     Exhibit 111: Chart on US – Market size and forecast 2022-2027 ($ million) 
o     Exhibit 112: Data Table on US – Market size and forecast 2022-2027 ($ million) 
o     Exhibit 113: Chart on US – Year-over-year growth 2022-2027 (%) 
o     Exhibit 114: Data Table on US – Year-over-year growth 2022-2027 (%) 
o     10.8 Germany – Market size and forecast 2022-2027 
o     Exhibit 115: Chart on Germany – Market size and forecast 2022-2027 ($ million) 
o     Exhibit 116: Data Table on Germany – Market size and forecast 2022-2027 ($ million) 
o     Exhibit 117: Chart on Germany – Year-over-year growth 2022-2027 (%) 
o     Exhibit 118: Data Table on Germany – Year-over-year growth 2022-2027 (%) 
o     10.9 UK – Market size and forecast 2022-2027 
o     Exhibit 119: Chart on UK – Market size and forecast 2022-2027 ($ million) 
o     Exhibit 120: Data Table on UK – Market size and forecast 2022-2027 ($ million) 
o     Exhibit 121: Chart on UK – Year-over-year growth 2022-2027 (%) 
o     Exhibit 122: Data Table on UK – Year-over-year growth 2022-2027 (%) 
o     10.10 China – Market size and forecast 2022-2027 
o     Exhibit 123: Chart on China – Market size and forecast 2022-2027 ($ million) 
o     Exhibit 124: Data Table on China – Market size and forecast 2022-2027 ($ million) 
o     Exhibit 125: Chart on China – Year-over-year growth 2022-2027 (%) 
o     Exhibit 126: Data Table on China – Year-over-year growth 2022-2027 (%) 
o     10.11 Canada – Market size and forecast 2022-2027 
o     Exhibit 127: Chart on Canada – Market size and forecast 2022-2027 ($ million) 
o     Exhibit 128: Data Table on Canada – Market size and forecast 2022-2027 ($ million) 
o     Exhibit 129: Chart on Canada – Year-over-year growth 2022-2027 (%) 
o     Exhibit 130: Data Table on Canada – Year-over-year growth 2022-2027 (%) 
o     10.12 Market opportunity By Geographical Landscape 
o     Exhibit 131: Market opportunity By Geographical Landscape ($ million) 
o     Exhibit 132: Data Tables on Market opportunity By Geographical Landscape ($ million) 
•     11 Drivers, Challenges, and Trends 
o     11.1 Market drivers 
o     11.2 Market challenges 
o     11.3 Impact of drivers and challenges 
o     Exhibit 133: Impact of drivers and challenges in 2022 and 2027 
o     11.4 Market trends 
•     12 Vendor Landscape 
o     12.1 Overview 
o     12.2 Vendor landscape 
o     Exhibit 134: Overview on Criticality of inputs and Factors of differentiation 
o     12.3 Landscape disruption 
o     Exhibit 135: Overview on factors of disruption 
o     12.4 Industry risks 
o     Exhibit 136: Impact of key risks on business 
•     13 Vendor Analysis 
o     13.1 Vendors covered 
o     Exhibit 137: Vendors covered 
o     13.2 Market positioning of vendors 
o     Exhibit 138: Matrix on vendor position and classification 
o     13.3 AstraZeneca Plc 
o     Exhibit 139: AstraZeneca Plc – Overview 
o     Exhibit 140: AstraZeneca Plc – Product / Service 
o     Exhibit 141: AstraZeneca Plc – Key news 
o     Exhibit 142: AstraZeneca Plc – Key offerings 
o     13.4 Becton Dickinson and Co. 
o     Exhibit 143: Becton Dickinson and Co. – Overview 
o     Exhibit 144: Becton Dickinson and Co. – Business segments 
o     Exhibit 145: Becton Dickinson and Co. – Key news 
o     Exhibit 146: Becton Dickinson and Co. – Key offerings 
o     Exhibit 147: Becton Dickinson and Co. – Segment focus 
o     13.5 bioMerieux SA 
o     Exhibit 148: bioMerieux SA – Overview 
o     Exhibit 149: bioMerieux SA – Product / Service 
o     Exhibit 150: bioMerieux SA – Key offerings 
o     13.6 DiaSorin SpA 
o     Exhibit 151: DiaSorin SpA – Overview 
o     Exhibit 152: DiaSorin SpA – Business segments 
o     Exhibit 153: DiaSorin SpA – Key news 
o     Exhibit 154: DiaSorin SpA – Key offerings 
o     Exhibit 155: DiaSorin SpA – Segment focus 
o     13.7 F. Hoffmann La Roche Ltd. 
o     Exhibit 156: F. Hoffmann La Roche Ltd. – Overview 
o     Exhibit 157: F. Hoffmann La Roche Ltd. – Business segments 
o     Exhibit 158: F. Hoffmann La Roche Ltd. – Key news 
o     Exhibit 159: F. Hoffmann La Roche Ltd. – Key offerings 
o     Exhibit 160: F. Hoffmann La Roche Ltd. – Segment focus 
o     13.8 Ferring BV 
o     Exhibit 161: Ferring BV – Overview 
o     Exhibit 162: Ferring BV – Product / Service 
o     Exhibit 163: Ferring BV – Key offerings 
o     13.9 Fujirebio Holdings Inc. 
o     Exhibit 164: Fujirebio Holdings Inc. – Overview 
o     Exhibit 165: Fujirebio Holdings Inc. – Product / Service 
o     Exhibit 166: Fujirebio Holdings Inc. – Key offerings 
o     13.10 Hologic Inc. 
o     Exhibit 167: Hologic Inc. – Overview 
o     Exhibit 168: Hologic Inc. – Business segments 
o     Exhibit 169: Hologic Inc. – Key news 
o     Exhibit 170: Hologic Inc. – Key offerings 
o     Exhibit 171: Hologic Inc. – Segment focus 
o     13.11 Huvepharma 
o     Exhibit 172: Huvepharma – Overview 
o     Exhibit 173: Huvepharma – Product / Service 
o     Exhibit 174: Huvepharma – Key offerings 
o     13.12 Novartis AG 
o     Exhibit 175: Novartis AG – Overview 
o     Exhibit 176: Novartis AG – Business segments 
o     Exhibit 177: Novartis AG – Key offerings 
o     Exhibit 178: Novartis AG – Segment focus 
o     13.13 Olympus Corp. 
o     Exhibit 179: Olympus Corp. – Overview 
o     Exhibit 180: Olympus Corp. – Business segments 
o     Exhibit 181: Olympus Corp. – Key news 
o     Exhibit 182: Olympus Corp. – Key offerings 
o     Exhibit 183: Olympus Corp. – Segment focus 
o     13.14 Pfizer Inc. 
o     Exhibit 184: Pfizer Inc. – Overview 
o     Exhibit 185: Pfizer Inc. – Product / Service 
o     Exhibit 186: Pfizer Inc. – Key news 
o     Exhibit 187: Pfizer Inc. – Key offerings 
o     13.15 QIAGEN NV 
o     Exhibit 188: QIAGEN NV – Overview 
o     Exhibit 189: QIAGEN NV – Product / Service 
o     Exhibit 190: QIAGEN NV – Key news 
o     Exhibit 191: QIAGEN NV – Key offerings 
o     13.16 Siemens AG 
o     Exhibit 192: Siemens AG – Overview 
o     Exhibit 193: Siemens AG – Business segments 
o     Exhibit 194: Siemens AG – Key news 
o     Exhibit 195: Siemens AG – Key offerings 
o     Exhibit 196: Siemens AG – Segment focus 
o     13.17 Thermo Fisher Scientific Inc. 
o     Exhibit 197: Thermo Fisher Scientific Inc. – Overview 
o     Exhibit 198: Thermo Fisher Scientific Inc. – Business segments 
o     Exhibit 199: Thermo Fisher Scientific Inc. – Key news 
o     Exhibit 200: Thermo Fisher Scientific Inc. – Key offerings 
o     Exhibit 201: Thermo Fisher Scientific Inc. – Segment focus 
•     14 Appendix 
o     14.1 Scope of the report 
o     14.2 Inclusions and exclusions checklist 
o     Exhibit 202: Inclusions checklist 
o     Exhibit 203: Exclusions checklist 
o     14.3 Currency conversion rates for US$ 
o     Exhibit 204: Currency conversion rates for US$ 
o     14.4 Research methodology 
o     Exhibit 205: Research methodology 
o     Exhibit 206: Validation techniques employed for market sizing 
o     Exhibit 207: Information sources 
o     14.5 List of abbreviations 
o     Exhibit 208: List of abbreviations 
Exhibits: 
Exhibits1: Executive Summary – Chart on Market Overview 
Exhibits2: Executive Summary – Data Table on Market Overview 
Exhibits3: Executive Summary – Chart on Global Market Characteristics 
Exhibits4: Executive Summary – Chart on Market By Geographical Landscape 
Exhibits5: Executive Summary – Chart on Market Segmentation by Technology 
Exhibits6: Executive Summary – Chart on Market Segmentation by Product 
Exhibits7: Executive Summary – Chart on Market Segmentation by End-user 
Exhibits8: Executive Summary – Chart on Incremental Growth 
Exhibits9: Executive Summary – Data Table on Incremental Growth 
Exhibits10: Executive Summary – Chart on Vendor Market Positioning 
Exhibits11: Parent market 
Exhibits12: Market Characteristics 
Exhibits13: Offerings of vendors included in the market definition 
Exhibits14: Market segments 
Exhibits15: Chart on Global – Market size and forecast 2022-2027 ($ million) 
Exhibits16: Data Table on Global – Market size and forecast 2022-2027 ($ million) 
Exhibits17: Chart on Global Market: Year-over-year growth 2022-2027 (%) 
Exhibits18: Data Table on Global Market: Year-over-year growth 2022-2027 (%) 
Exhibits19: Historic Market Size – Data Table on Global clostridium diagnostics market 2017 – 2021 ($ million) 
Exhibits20: Historic Market Size – Technology Segment 2017 – 2021 ($ million) 
Exhibits21: Historic Market Size – Product Segment 2017 – 2021 ($ million) 
Exhibits22: Historic Market Size – End user Segment 2017 – 2021 ($ million) 
Exhibits23: Historic Market Size – Geography Segment 2017 – 2021 ($ million) 
Exhibits24: Historic Market Size – Country Segment 2017 – 2021 ($ million) 
Exhibits25: Five forces analysis – Comparison between 2022 and 2027 
Exhibits26: Chart on Bargaining power of buyers – Impact of key factors 2022 and 2027 
Exhibits27: Bargaining power of suppliers – Impact of key factors in 2022 and 2027 
Exhibits28: Threat of new entrants – Impact of key factors in 2022 and 2027 
Exhibits29: Threat of substitutes – Impact of key factors in 2022 and 2027 
Exhibits30: Threat of rivalry – Impact of key factors in 2022 and 2027 
Exhibits31: Chart on Market condition – Five forces 2022 and 2027 
Exhibits32: Chart on Technology – Market share 2022-2027 (%) 
Exhibits33: Data Table on Technology – Market share 2022-2027 (%) 
Exhibits34: Chart on Comparison by Technology 
Exhibits35: Data Table on Comparison by Technology 
Exhibits36: Chart on Immunoassays – Market size and forecast 2022-2027 ($ million) 
Exhibits37: Data Table on Immunoassays – Market size and forecast 2022-2027 ($ million) 
Exhibits38: Chart on Immunoassays – Year-over-year growth 2022-2027 (%) 
Exhibits39: Data Table on Immunoassays – Year-over-year growth 2022-2027 (%) 
Exhibits40: Chart on Molecular diagnostics – Market size and forecast 2022-2027 ($ million) 
Exhibits41: Data Table on Molecular diagnostics – Market size and forecast 2022-2027 ($ million) 
Exhibits42: Chart on Molecular diagnostics – Year-over-year growth 2022-2027 (%) 
Exhibits43: Data Table on Molecular diagnostics – Year-over-year growth 2022-2027 (%) 
Exhibits44: Market opportunity by Technology ($ million) 
Exhibits45: Data Table on Market opportunity by Technology ($ million) 
Exhibits46: Chart on Product – Market share 2022-2027 (%) 
Exhibits47: Data Table on Product – Market share 2022-2027 (%) 
Exhibits48: Chart on Comparison by Product 
Exhibits49: Data Table on Comparison by Product 
Exhibits50: Chart on Clostridium difficile – Market size and forecast 2022-2027 ($ million) 
Exhibits51: Data Table on Clostridium difficile – Market size and forecast 2022-2027 ($ million) 
Exhibits52: Chart on Clostridium difficile – Year-over-year growth 2022-2027 (%) 
Exhibits53: Data Table on Clostridium difficile – Year-over-year growth 2022-2027 (%) 
Exhibits54: Chart on Clostridium perfringens – Market size and forecast 2022-2027 ($ million) 
Exhibits55: Data Table on Clostridium perfringens – Market size and forecast 2022-2027 ($ million) 
Exhibits56: Chart on Clostridium perfringens – Year-over-year growth 2022-2027 (%) 
Exhibits57: Data Table on Clostridium perfringens – Year-over-year growth 2022-2027 (%) 
Exhibits58: Chart on Clostridium botulinum – Market size and forecast 2022-2027 ($ million) 
Exhibits59: Data Table on Clostridium botulinum – Market size and forecast 2022-2027 ($ million) 
Exhibits60: Chart on Clostridium botulinum – Year-over-year growth 2022-2027 (%) 
Exhibits61: Data Table on Clostridium botulinum – Year-over-year growth 2022-2027 (%) 
Exhibits62: Chart on Clostridium tetani – Market size and forecast 2022-2027 ($ million) 
Exhibits63: Data Table on Clostridium tetani – Market size and forecast 2022-2027 ($ million) 
Exhibits64: Chart on Clostridium tetani – Year-over-year growth 2022-2027 (%) 
Exhibits65: Data Table on Clostridium tetani – Year-over-year growth 2022-2027 (%) 
Exhibits66: Chart on Clostridium sordellii – Market size and forecast 2022-2027 ($ million) 
Exhibits67: Data Table on Clostridium sordellii – Market size and forecast 2022-2027 ($ million) 
Exhibits68: Chart on Clostridium sordellii – Year-over-year growth 2022-2027 (%) 
Exhibits69: Data Table on Clostridium sordellii – Year-over-year growth 2022-2027 (%) 
Exhibits70: Market opportunity by Product ($ million) 
Exhibits71: Data Table on Market opportunity by Product ($ million) 
Exhibits72: Chart on End-user – Market share 2022-2027 (%) 
Exhibits73: Data Table on End-user – Market share 2022-2027 (%) 
Exhibits74: Chart on Comparison by End-user 
Exhibits75: Data Table on Comparison by End-user 
Exhibits76: Chart on Hospitals – Market size and forecast 2022-2027 ($ million) 
Exhibits77: Data Table on Hospitals – Market size and forecast 2022-2027 ($ million) 
Exhibits78: Chart on Hospitals – Year-over-year growth 2022-2027 (%) 
Exhibits79: Data Table on Hospitals – Year-over-year growth 2022-2027 (%) 
Exhibits80: Chart on Independent laboratories – Market size and forecast 2022-2027 ($ million) 
Exhibits81: Data Table on Independent laboratories – Market size and forecast 2022-2027 ($ million) 
Exhibits82: Chart on Independent laboratories – Year-over-year growth 2022-2027 (%) 
Exhibits83: Data Table on Independent laboratories – Year-over-year growth 2022-2027 (%) 
Exhibits84: Chart on Physicians clinics – Market size and forecast 2022-2027 ($ million) 
Exhibits85: Data Table on Physicians clinics – Market size and forecast 2022-2027 ($ million) 
Exhibits86: Chart on Physicians clinics – Year-over-year growth 2022-2027 (%) 
Exhibits87: Data Table on Physicians clinics – Year-over-year growth 2022-2027 (%) 
Exhibits88: Market opportunity by End-user ($ million) 
Exhibits89: Data Table on Market opportunity by End-user ($ million) 
Exhibits90: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria 
Exhibits91: Chart on Market share By Geographical Landscape 2022-2027 (%) 
Exhibits92: Data Table on Market share By Geographical Landscape 2022-2027 (%) 
Exhibits93: Chart on Geographic comparison 
Exhibits94: Data Table on Geographic comparison 
Exhibits95: Chart on North America – Market size and forecast 2022-2027 ($ million) 
Exhibits96: Data Table on North America – Market size and forecast 2022-2027 ($ million) 
Exhibits97: Chart on North America – Year-over-year growth 2022-2027 (%) 
Exhibits98: Data Table on North America – Year-over-year growth 2022-2027 (%) 
Exhibits99: Chart on Europe – Market size and forecast 2022-2027 ($ million) 
Exhibits100: Data Table on Europe – Market size and forecast 2022-2027 ($ million) 
Exhibits101: Chart on Europe – Year-over-year growth 2022-2027 (%) 
Exhibits102: Data Table on Europe – Year-over-year growth 2022-2027 (%) 
Exhibits103: Chart on Asia – Market size and forecast 2022-2027 ($ million) 
Exhibits104: Data Table on Asia – Market size and forecast 2022-2027 ($ million) 
Exhibits105: Chart on Asia – Year-over-year growth 2022-2027 (%) 
Exhibits106: Data Table on Asia – Year-over-year growth 2022-2027 (%) 
Exhibits107: Chart on Rest of World (ROW) – Market size and forecast 2022-2027 ($ million) 
Exhibits108: Data Table on Rest of World (ROW) – Market size and forecast 2022-2027 ($ million) 
Exhibits109: Chart on Rest of World (ROW) – Year-over-year growth 2022-2027 (%) 
Exhibits110: Data Table on Rest of World (ROW) – Year-over-year growth 2022-2027 (%) 
Exhibits111: Chart on US – Market size and forecast 2022-2027 ($ million) 
Exhibits112: Data Table on US – Market size and forecast 2022-2027 ($ million) 
Exhibits113: Chart on US – Year-over-year growth 2022-2027 (%) 
Exhibits114: Data Table on US – Year-over-year growth 2022-2027 (%) 
Exhibits115: Chart on Germany – Market size and forecast 2022-2027 ($ million) 
Exhibits116: Data Table on Germany – Market size and forecast 2022-2027 ($ million) 
Exhibits117: Chart on Germany – Year-over-year growth 2022-2027 (%) 
Exhibits118: Data Table on Germany – Year-over-year growth 2022-2027 (%) 
Exhibits119: Chart on UK – Market size and forecast 2022-2027 ($ million) 
Exhibits120: Data Table on UK – Market size and forecast 2022-2027 ($ million) 
Exhibits121: Chart on UK – Year-over-year growth 2022-2027 (%) 
Exhibits122: Data Table on UK – Year-over-year growth 2022-2027 (%) 
Exhibits123: Chart on China – Market size and forecast 2022-2027 ($ million) 
Exhibits124: Data Table on China – Market size and forecast 2022-2027 ($ million) 
Exhibits125: Chart on China – Year-over-year growth 2022-2027 (%) 
Exhibits126: Data Table on China – Year-over-year growth 2022-2027 (%) 
Exhibits127: Chart on Canada – Market size and forecast 2022-2027 ($ million) 
Exhibits128: Data Table on Canada – Market size and forecast 2022-2027 ($ million) 
Exhibits129: Chart on Canada – Year-over-year growth 2022-2027 (%) 
Exhibits130: Data Table on Canada – Year-over-year growth 2022-2027 (%) 
Exhibits131: Market opportunity By Geographical Landscape ($ million) 
Exhibits132: Data Tables on Market opportunity By Geographical Landscape ($ million) 
Exhibits133: Impact of drivers and challenges in 2022 and 2027 
Exhibits134: Overview on Criticality of inputs and Factors of differentiation 
Exhibits135: Overview on factors of disruption 
Exhibits136: Impact of key risks on business 
Exhibits137: Vendors covered 
Exhibits138: Matrix on vendor position and classification 
Exhibits139: AstraZeneca Plc – Overview 
Exhibits140: AstraZeneca Plc – Product / Service 
Exhibits141: AstraZeneca Plc – Key news 
Exhibits142: AstraZeneca Plc – Key offerings 
Exhibits143: Becton Dickinson and Co. – Overview 
Exhibits144: Becton Dickinson and Co. – Business segments 
Exhibits145: Becton Dickinson and Co. – Key news 
Exhibits146: Becton Dickinson and Co. – Key offerings 
Exhibits147: Becton Dickinson and Co. – Segment focus 
Exhibits148: bioMerieux SA – Overview 
Exhibits149: bioMerieux SA – Product / Service 
Exhibits150: bioMerieux SA – Key offerings 
Exhibits151: DiaSorin SpA – Overview 
Exhibits152: DiaSorin SpA – Business segments 
Exhibits153: DiaSorin SpA – Key news 
Exhibits154: DiaSorin SpA – Key offerings 
Exhibits155: DiaSorin SpA – Segment focus 
Exhibits156: F. Hoffmann La Roche Ltd. – Overview 
Exhibits157: F. Hoffmann La Roche Ltd. – Business segments 
Exhibits158: F. Hoffmann La Roche Ltd. – Key news 
Exhibits159: F. Hoffmann La Roche Ltd. – Key offerings 
Exhibits160: F. Hoffmann La Roche Ltd. – Segment focus 
Exhibits161: Ferring BV – Overview 
Exhibits162: Ferring BV – Product / Service 
Exhibits163: Ferring BV – Key offerings 
Exhibits164: Fujirebio Holdings Inc. – Overview 
Exhibits165: Fujirebio Holdings Inc. – Product / Service 
Exhibits166: Fujirebio Holdings Inc. – Key offerings 
Exhibits167: Hologic Inc. – Overview 
Exhibits168: Hologic Inc. – Business segments 
Exhibits169: Hologic Inc. – Key news 
Exhibits170: Hologic Inc. – Key offerings 
Exhibits171: Hologic Inc. – Segment focus 
Exhibits172: Huvepharma – Overview 
Exhibits173: Huvepharma – Product / Service 
Exhibits174: Huvepharma – Key offerings 
Exhibits175: Novartis AG – Overview 
Exhibits176: Novartis AG – Business segments 
Exhibits177: Novartis AG – Key offerings 
Exhibits178: Novartis AG – Segment focus 
Exhibits179: Olympus Corp. – Overview 
Exhibits180: Olympus Corp. – Business segments 
Exhibits181: Olympus Corp. – Key news 
Exhibits182: Olympus Corp. – Key offerings 
Exhibits183: Olympus Corp. – Segment focus 
Exhibits184: Pfizer Inc. – Overview 
Exhibits185: Pfizer Inc. – Product / Service 
Exhibits186: Pfizer Inc. – Key news 
Exhibits187: Pfizer Inc. – Key offerings 
Exhibits188: QIAGEN NV – Overview 
Exhibits189: QIAGEN NV – Product / Service 
Exhibits190: QIAGEN NV – Key news 
Exhibits191: QIAGEN NV – Key offerings 
Exhibits192: Siemens AG – Overview 
Exhibits193: Siemens AG – Business segments 
Exhibits194: Siemens AG – Key news 
Exhibits195: Siemens AG – Key offerings 
Exhibits196: Siemens AG – Segment focus 
Exhibits197: Thermo Fisher Scientific Inc. – Overview 
Exhibits198: Thermo Fisher Scientific Inc. – Business segments 
Exhibits199: Thermo Fisher Scientific Inc. – Key news 
Exhibits200: Thermo Fisher Scientific Inc. – Key offerings 
Exhibits201: Thermo Fisher Scientific Inc. – Segment focus 
Exhibits202: Inclusions checklist 
Exhibits203: Exclusions checklist 
Exhibits204: Currency conversion rates for US$ 
Exhibits205: Research methodology 
Exhibits206: Validation techniques employed for market sizing 
Exhibits207: Information sources 
Exhibits208: List of abbreviations 
 | 
| ※본 조사보고서 [세계의 클로스트리듐 진단 시장 (2023년~2027년)] (코드 : IRTNTR75006-23) 판매에 관한 면책사항을 반드시 확인하세요. |  
 
 | ※본 조사보고서 [세계의 클로스트리듐 진단 시장 (2023년~2027년)] 에 대해서 E메일 문의는 여기를 클릭하세요. |  
 
 ※당 사이트에 없는 보고서도 취급 가능한 경우가 많으니 문의 주세요!   세계의 클로스트리듐 진단 시장 (2023년~2027년)